1,327
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Modelling the impact of mass administration of ivermectin in the treatment of onchocerciasis (river blindness)

ORCID Icon, & | (Reviewing Editor)
Article: 1429700 | Received 03 Aug 2017, Accepted 10 Jan 2018, Published online: 04 Feb 2018

Figures & data

Figure 1. A compartmental representation of the epidemics and treatment of onchocerciasis. It is important to note that the model proposed here is an extension of the previous model studied in Omondi et al. (Citation2017).

Figure 1. A compartmental representation of the epidemics and treatment of onchocerciasis. It is important to note that the model proposed here is an extension of the previous model studied in Omondi et al. (Citation2017).

Figure 2. Comparison of the actual infected individuals and the estimated infected individuals.

Figure 2. Comparison of the actual infected individuals and the estimated infected individuals.

Table 1. Estimated parameter values in the model for onchocerciasis case. The rates are given per day

Figure 3. Tornado plots of partial rank correlation coefficients (PRCCs) of the parameters that influence R0 for the input parameters using the values in Table . Parameters with PRCC >0 increase R0 when they are increased whereas parameters with PRCC <0 decrease R0 when they are increased.

Figure 3. Tornado plots of partial rank correlation coefficients (PRCCs) of the parameters that influence R0 for the input parameters using the values in Table 1. Parameters with PRCC >0 increase R0 when they are increased whereas parameters with PRCC <0 decrease R0 when they are increased.

Figure 4. The Monte Carlo simulations for the three parameters with the greatest influence on the R0: the transmission contact rate in humans, the transmission contact rate in the vector and the vector death rate for the input parameters using the values in Table and 1,000 simulations per run. Eradication is only possible if the transmissibilities are extremely small or if the vector death rate is extremely high.

Figure 4. The Monte Carlo simulations for the three parameters with the greatest influence on the R0: the transmission contact rate in humans, the transmission contact rate in the vector and the vector death rate for the input parameters using the values in Table 1 and 1,000 simulations per run. Eradication is only possible if the transmissibilities are extremely small or if the vector death rate is extremely high.

Figure 5. Eradication threshold for the three parameters with the greatest influence on R0.

Figure 5. Eradication threshold for the three parameters with the greatest influence on R0.

Figure 6. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.10,R0=1.2412,b1=0.0009,b2=0.35,βh=0.00562,βv=0.00243,φ=0.025,μv=0.012.

Figure 6. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.10,R0=1.2412,b1=0.0009,b2=0.35,βh=0.00562,βv=0.00243,φ=0.025,μv=0.012.

Figure 7. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.65,R0=1.2412,b1=0.0009,b2=0.35,βh=0.00562,βv=0.00243,φ=0.025,μv=0.012. Note that increasing α improves the outcome but does not lead to eradication.

Figure 7. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.65,R0=1.2412,b1=0.0009,b2=0.35,βh=0.00562,βv=0.00243,φ=0.025,μv=0.012. Note that increasing α improves the outcome but does not lead to eradication.

Figure 8. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.10,R0=0.9352,b1=0.0009,b2=0.35,βh=0.00443,φ=0.025,βv=0.00175,μv=0.012. Non-fixed adminsitration may produce lower overall numbers of infected individuals, but the outcome is not predictable.

Figure 8. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.10,R0=0.9352,b1=0.0009,b2=0.35,βh=0.00443,φ=0.025,βv=0.00175,μv=0.012. Non-fixed adminsitration may produce lower overall numbers of infected individuals, but the outcome is not predictable.

Figure 9. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.65,R0=0.9352,b1=0.0009,b2=0.35,βh=0.00443,φ=0.025,βv=0.00175,μv=0.012. Non-fixed administration may produces bursts of infection, even if the disease would be otherwise kept at low levels.

Figure 9. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.65,R0=0.9352,b1=0.0009,b2=0.35,βh=0.00443,φ=0.025,βv=0.00175,μv=0.012. Non-fixed administration may produces bursts of infection, even if the disease would be otherwise kept at low levels.

Figure 10. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.1,R0=0.1181 using parameter values in Table . Note that non-fixed administration may have a delaying or preventative effect on eradication.

Figure 10. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.1,R0=0.1181 using parameter values in Table 1. Note that non-fixed administration may have a delaying or preventative effect on eradication.

Figure 11. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.65,R0=0.1181 using parameter values in Table . Increasing α hastens eradication, in both the fixed and non-fixed case.

Figure 11. System behaviour for fixed and non-fixed mass administration of ivermectin with α=0.65,R0=0.1181 using parameter values in Table 1. Increasing α hastens eradication, in both the fixed and non-fixed case.